Bausch Health Companies Inc. Stock
Bausch Health Companies Inc. took a tumble today and lost -€0.194 (-4.040%).
Our community identified positive and negative aspects for Bausch Health Companies Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bausch Health Companies Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -4.040% | -7.459% | -6.790% | -30.539% | -23.797% | -46.856% | -83.240% |
| Repligen Corp. | -4.320% | -8.694% | -13.935% | -30.313% | -26.553% | -40.580% | -33.686% |
| Opko Health Inc. | 3.320% | 0.794% | -3.018% | -41.515% | -9.209% | 0.010% | -69.979% |
| Amicus Therapeutics Inc. | 0.000% | 1.667% | 2.521% | 45.238% | 1.667% | 4.524% | 39.429% |
Comments
Bausch Health Cos (NYSE:BHC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat